What we learned about headache during the COVID-19 pandemic: literature review
Headache is one of the most common neurological symptoms associated with coronavirus disease 19 (COVID-19), which can mimic primary headache phenotypes. COVID-19 and quarantine have affected both the course of primary headache and patient care strategies. The safety of migraine treatment with anti-...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Vilnius University Press
2023-10-01
|
| Series: | Neurologijos seminarai |
| Subjects: | |
| Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/33267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832593105336926208 |
|---|---|
| author | E. Januškevičiūtė J. Grigaitė K. Ryliškienė |
| author_facet | E. Januškevičiūtė J. Grigaitė K. Ryliškienė |
| author_sort | E. Januškevičiūtė |
| collection | DOAJ |
| description |
Headache is one of the most common neurological symptoms associated with coronavirus disease 19 (COVID-19), which can mimic primary headache phenotypes. COVID-19 and quarantine have affected both the course of primary headache and patient care strategies. The safety of migraine treatment with anti-CGRP (calcitonin gene-related peptides) monoclonal drugs has become important. Another challenge posed by the introduction of mass vaccination is vaccine-related headache, the most common neurological adverse event, and a less common complication, cerebral venous thrombosis. The article provides a brief overview of COVID-19 induced headache and its features, vaccination-induced headache, the impact of COVID-19 and quarantine on primary headache, the safety of anti-CGRP monoclonals, and the advantages and disadvantages of remote consultations on primary headaches.
|
| format | Article |
| id | doaj-art-36f81bf345944b1fbaad6f825c0af68b |
| institution | Kabale University |
| issn | 1392-3064 2424-5917 |
| language | English |
| publishDate | 2023-10-01 |
| publisher | Vilnius University Press |
| record_format | Article |
| series | Neurologijos seminarai |
| spelling | doaj-art-36f81bf345944b1fbaad6f825c0af68b2025-01-20T18:22:10ZengVilnius University PressNeurologijos seminarai1392-30642424-59172023-10-01263 (93)10.29014/NS.2022.26.16What we learned about headache during the COVID-19 pandemic: literature reviewE. Januškevičiūtė0J. Grigaitė1K. Ryliškienė2Vilnius University, LithuaniaVilnius University, LithuaniaVilnius University, Lithuania Headache is one of the most common neurological symptoms associated with coronavirus disease 19 (COVID-19), which can mimic primary headache phenotypes. COVID-19 and quarantine have affected both the course of primary headache and patient care strategies. The safety of migraine treatment with anti-CGRP (calcitonin gene-related peptides) monoclonal drugs has become important. Another challenge posed by the introduction of mass vaccination is vaccine-related headache, the most common neurological adverse event, and a less common complication, cerebral venous thrombosis. The article provides a brief overview of COVID-19 induced headache and its features, vaccination-induced headache, the impact of COVID-19 and quarantine on primary headache, the safety of anti-CGRP monoclonals, and the advantages and disadvantages of remote consultations on primary headaches. https://www.journals.vu.lt/neurologijos_seminarai/article/view/33267COVID-19 induced headacheprimary headachequarantineremote consultationsanti-CGRP monoclonal antibodies |
| spellingShingle | E. Januškevičiūtė J. Grigaitė K. Ryliškienė What we learned about headache during the COVID-19 pandemic: literature review Neurologijos seminarai COVID-19 induced headache primary headache quarantine remote consultations anti-CGRP monoclonal antibodies |
| title | What we learned about headache during the COVID-19 pandemic: literature review |
| title_full | What we learned about headache during the COVID-19 pandemic: literature review |
| title_fullStr | What we learned about headache during the COVID-19 pandemic: literature review |
| title_full_unstemmed | What we learned about headache during the COVID-19 pandemic: literature review |
| title_short | What we learned about headache during the COVID-19 pandemic: literature review |
| title_sort | what we learned about headache during the covid 19 pandemic literature review |
| topic | COVID-19 induced headache primary headache quarantine remote consultations anti-CGRP monoclonal antibodies |
| url | https://www.journals.vu.lt/neurologijos_seminarai/article/view/33267 |
| work_keys_str_mv | AT ejanuskeviciute whatwelearnedaboutheadacheduringthecovid19pandemicliteraturereview AT jgrigaite whatwelearnedaboutheadacheduringthecovid19pandemicliteraturereview AT kryliskiene whatwelearnedaboutheadacheduringthecovid19pandemicliteraturereview |